Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Evaluation of vascular quality of life questionnaire in dialysis patients with peripheral arterial disease treated by low-density lipoprotein apheresis

Fig. 2

Time course of lipid profile. White square shows the non-CLI group (N = 17). Black triangle represents the CLI group (N = 15). A before the first LDL-A. B after the first LDL-A:.C at tenth LDL-A. D 1 month after completion of LDL-A treatment. a–c At starting point (point A), all of the apoB/apoA-I ratio, MDA-LDL, and RLP-C values were higher in the CLI group, but not statistically different between the CLI and non-CLI groups. a apoB/apoA-I ratio improved after the first LDL apheresis (LDL-A) and in the beginning of tenth LDL-A significantly. However, it returned equivalent to the level of starting point 1 month after completion of LDL-A treatment. b MDA-LDL decreased significantly after the first LDL-A. However, there was no significant difference between the beginning of the first and tenth LDL-A. c As for RLP-C, in the CLI group, a significant decrease was confirmed after the first LDL-A and in the beginning of tenth LDL-A, compared with that in the beginning of the first LDL-A, but no significant difference was found 1 month after completion of LDL-A treatment. In the non-CLI group, a significant decrease was detected only just after the first LDL-A. All values are expressed as mean ± SD. *P < 0.01. **P < 0.05

Back to article page